153 related articles for article (PubMed ID: 7793892)
1. SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.
Karyotakis NC; Dignani MC; Anaissie EJ
Antimicrob Agents Chemother; 1995 Mar; 39(3):775-7. PubMed ID: 7793892
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice.
Karyotakis NC; Anaissie EJ; Hachem R; Dignani MC; Samonis G
J Infect Dis; 1993 Nov; 168(5):1311-3. PubMed ID: 8228370
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of escalating doses of liposomal amphotericin B (AmBisome) against hematogenous Candida lusitaniae and Candida krusei infection in neutropenic mice.
Karyotakis NC; Anaissie EJ
Antimicrob Agents Chemother; 1994 Nov; 38(11):2660-2. PubMed ID: 7872764
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.
Anaissie EJ; Hachem R; Karyotakis NC; Gokaslan A; Dignani MC; Stephens LC; Tin-U CK
Antimicrob Agents Chemother; 1994 Nov; 38(11):2541-4. PubMed ID: 7872744
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.
Majithiya J; Sharp A; Parmar A; Denning DW; Warn PA
J Antimicrob Chemother; 2009 Jan; 63(1):161-6. PubMed ID: 19008255
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
Van t Wout JW; Mattie H; van Furth R
Antimicrob Agents Chemother; 1989 Feb; 33(2):147-51. PubMed ID: 2541654
[TBL] [Abstract][Full Text] [Related]
8. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
[TBL] [Abstract][Full Text] [Related]
9. Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
Anaissie EJ; Karyotakis NC; Hachem R; Dignani MC; Rex JH; Paetznick V
J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024
[TBL] [Abstract][Full Text] [Related]
10. Alternatives to amphotericin B for Candida rugosa infection.
Hernandez S; Gonzalez GM; McCarthy DI; Colombo AL; Najvar LK; Bocanegera R; Graybill JR
J Antimicrob Chemother; 2004 Aug; 54(2):477-80. PubMed ID: 15215225
[TBL] [Abstract][Full Text] [Related]
11. Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei.
Fisher MA; Shen SH; Haddad J; Tarry WF
Antimicrob Agents Chemother; 1989 Sep; 33(9):1443-6. PubMed ID: 2554797
[TBL] [Abstract][Full Text] [Related]
12. Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections.
Karyotakis NC; Dignani MC; Hachem R; Anaissie EJ
Antimicrob Agents Chemother; 1995 Feb; 39(2):571-3. PubMed ID: 7726538
[TBL] [Abstract][Full Text] [Related]
13. Treatment of disseminated Torulopsis glabrata infection with DO870 and amphotericin B.
Atkinson BA; Bocanegra R; Colombo AL; Graybill JR
Antimicrob Agents Chemother; 1994 Jul; 38(7):1604-7. PubMed ID: 7979293
[TBL] [Abstract][Full Text] [Related]
14. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
Fong IW; Bannatyne RM; Cheng PC
Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716
[TBL] [Abstract][Full Text] [Related]
15. Treatment of murine pulmonary blastomycosis with SCH 39304, a new triazole antifungal agent.
Sugar AM; Picard M; Noble L
Antimicrob Agents Chemother; 1990 May; 34(5):896-8. PubMed ID: 2360825
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of triazoles in a murine disseminated infection by Candida krusei.
Mariné M; Pastor FJ; Serena C; Guarro J
Antimicrob Agents Chemother; 2009 Aug; 53(8):3585-8. PubMed ID: 19470509
[TBL] [Abstract][Full Text] [Related]
17. In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis.
Warn PA; Morrissey J; Moore CB; Denning DW
Antimicrob Agents Chemother; 2000 Oct; 44(10):2664-71. PubMed ID: 10991841
[TBL] [Abstract][Full Text] [Related]
18. Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.
Scorzoni L; de Lucas MP; Mesa-Arango AC; Fusco-Almeida AM; Lozano E; Cuenca-Estrella M; Mendes-Giannini MJ; Zaragoza O
PLoS One; 2013; 8(3):e60047. PubMed ID: 23555877
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.
Kobayashi GS; Travis SJ; Rinaldi MG; Medoff G
Antimicrob Agents Chemother; 1990 Apr; 34(4):524-8. PubMed ID: 2344160
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
Troke PF; Andrews RJ; Brammer KW; Marriott MS; Richardson K
Antimicrob Agents Chemother; 1985 Dec; 28(6):815-8. PubMed ID: 3002246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]